Cargando…

An In Vitro and In Vivo Evaluation of the Effect of Relacorilant on the Activity of Cytochrome P450 Drug Metabolizing Enzymes

Relacorilant is a selective modulator of the glucocorticoid receptor in development for the treatment of several serious diseases. The widely used cocktail method was employed to assess relacorilant's effect on various cytochrome P450 (CYP) drug metabolizing enzymes in vitro and in vivo. Inhibi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Custodio, Joseph M., Donaldson, Kirsteen M., Hunt, Hazel J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Drug Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818505/ https://www.ncbi.nlm.nih.gov/pubmed/32869328 http://dx.doi.org/10.1002/jcph.1731

Ejemplares similares

Evaluation of Potential Drug‐Drug Interaction Risk of Pexidartinib With Substrates of Cytochrome P450 and P‐Glycoprotein
por: Zahir, Hamim, et al.
Publicado: (2020)

Effects of Ospemifene on Drug Metabolism Mediated by Cytochrome P450 Enzymes in Humans in Vitro and in Vivo
por: Turpeinen, Miia, et al.
Publicado: (2013)

Cytochrome P450 Enzymes and Drug Metabolism in Humans
por: Zhao, Mingzhe, et al.
Publicado: (2021)

Use of a cocktail probe to assess potential drug interactions with cytochrome P450 after administration of belatacept, a costimulatory immunomodulator
por: Williams, Daphne, et al.
Publicado: (2016)

Drug‐Drug Interaction Study to Assess the Effect of Cytochrome P450 Inhibition and Induction on the Pharmacokinetics of the Novel Cereblon Modulator Avadomide (CC‐122) in Healthy Adult Subjects
por: Ogasawara, Ken, et al.
Publicado: (2019)

In Vitro and In Vivo Effect of Xylopic Acid on Cytochrome P450 Enzymes
por: Agbenyeku, Mary A., et al.
Publicado: (2022)

Peripheral glucocorticoid receptor antagonism by relacorilant with modest HPA axis disinhibition
por: Viho, Eva M G, et al.
Publicado: (2022)

Effect of fermented red ginseng on cytochrome P450 and P‐glycoprotein activity in healthy subjects, as evaluated using the cocktail approach
por: Kim, Min‐Gul, et al.
Publicado: (2016)

In vivo Metabolism of Nifurtimox and the Drug-Drug Interaction Potential Including its Major Metabolites
por: Schulz, Simone I., et al.
Publicado: (2023)

The role of cytochrome P450 enzymes in carcinogen activation and detoxication: an in vivo–in vitro paradox
por: Reed, Lindsay, et al.
Publicado: (2018)

Effects of Upadacitinib Coadministration on the Pharmacokinetics of Sensitive Cytochrome P450 Probe Substrates: A Study With the Modified Cooperstown 5+1 Cocktail
por: Mohamed, Mohamed‐Eslam F., et al.
Publicado: (2019)

Cytochrome P450-Based Drug-Drug Interactions of Vonoprazan In Vitro and In Vivo
por: Wang, Yiran, et al.
Publicado: (2020)

The Engagement of Cytochrome P450 Enzymes in Tryptophan Metabolism
por: Haduch, Anna, et al.
Publicado: (2023)

Kinetics of cytochrome P450 enzymes for metabolism of sodium tanshinone IIA sulfonate in vitro
por: Ouyang, Dong-sheng, et al.
Publicado: (2016)

Inhibitory Effect of Lygodium Root on the Cytochrome P450 3A Enzyme in vitro and in vivo
por: Zhou, Yunfang, et al.
Publicado: (2020)

Cytochrome P450 2C19 enzyme, Cytochrome P450 2C9 enzyme, and Cytochrome P450 2D6 enzyme allelic variants and its possible effect on drug metabolism: A retrospective study
por: Naujokaitis, Domas, et al.
Publicado: (2021)

Cross-species analysis of hepatic cytochrome P450 and transport protein expression
por: Hammer, Helen, et al.
Publicado: (2020)

Role of cytochrome P-450 and related enzymes in the pulmonary metabolism of xenobiotics.
por: Philpot, R M, et al.
Publicado: (1984)

Characterization of furathiocarb metabolism in in-vitro human liver microsomes and recombinant cytochrome P450 enzymes
por: Abass, Khaled, et al.
Publicado: (2022)

Inhibition and Induction by Poziotinib of Different Rat Cytochrome P450 Enzymes In Vivo and in an In Vitro Cocktail Method
por: Wang, Jinhui, et al.
Publicado: (2021)

In vitro evaluation of the effects of 4-aminopyridine on cytochrome P450 enzymes
por: Caggiano, Anthony, et al.
Publicado: (2013)

In vitro inhibitory effect of lysionotin on the activity of cytochrome P450 enzymes
por: Li, Yang, et al.
Publicado: (2020)

In vitro study on the effect of cornin on the activity of cytochrome P450 enzymes
por: Zhang, Qun, et al.
Publicado: (2021)

In vitro study on the effect of peucedanol on the activity of cytochrome P450 enzymes
por: Zhang, Cun, et al.
Publicado: (2021)

A Multiscale Approach to Modelling Drug Metabolism by Membrane-Bound Cytochrome P450 Enzymes
por: Lonsdale, Richard, et al.
Publicado: (2014)

Roles of Human Liver Cytochrome P450 Enzymes in Tenatoprazole Metabolism
por: Le, Thien-Kim, et al.
Publicado: (2022)

Dysregulation of lncRNA and CircRNA Expression in Mouse Testes after Exposure to Triptolide
por: Xiong, Suping, et al.
Publicado: (2019)

An update on the role of intestinal cytochrome P450 enzymes in drug disposition
por: Xie, Fang, et al.
Publicado: (2016)

A history of the roles of cytochrome P450 enzymes in the toxicity of drugs
por: Guengerich, F. Peter
Publicado: (2020)

In Vitro Interaction of AB-FUBINACA with Human Cytochrome P450, UDP-Glucuronosyltransferase Enzymes and Drug Transporters
por: Kim, Sunjoo, et al.
Publicado: (2020)

Structure and function of the cytochrome P450 peroxygenase enzymes
por: Munro, Andrew W., et al.
Publicado: (2018)

In vitro inhibitory effects of Friedelin on human liver cytochrome P450 enzymes
por: Wei, Jinlan, et al.
Publicado: (2018)

In vitro inhibitory effects of kaempferitrin on human liver cytochrome P450 enzymes
por: Zhang, Ning, et al.
Publicado: (2019)

In vitro inhibitory effects of bergenin on human liver cytochrome P450 enzymes
por: Dong, Gang, et al.
Publicado: (2018)

In vitro inhibitory effects of dihydromyricetin on human liver cytochrome P450 enzymes
por: Liu, Lu, et al.
Publicado: (2017)

In vitro inhibitory effects of cepharanthine on human liver cytochrome P450 enzymes
por: Zhang, Xunge, et al.
Publicado: (2020)

PMON165 Favorable Liver Safety Profile of the Selective Glucocorticoid Receptor Modulator Relacorilant in Healthy and Hepatically Impaired Adults and in Patients with Cushing Syndrome
por: Moraitis, Andreas, et al.
Publicado: (2022)

Lack of Impact by SCY‐078, a First‐in‐Class Oral Fungicidal Glucan Synthase Inhibitor, on the Pharmacokinetics of Rosiglitazone, a Substrate for CYP450 2C8, Supports the Low Risk for Clinically Relevant Metabolic Drug‐Drug Interactions
por: Wring, Stephen, et al.
Publicado: (2018)

Role of Cytochrome P450 Enzymes in the Metabolic Activation of Tyrosine Kinase Inhibitors
por: Jackson, Klarissa D., et al.
Publicado: (2018)

Allosteric modulation of cytochrome P450 enzymes by the NADPH cytochrome P450 reductase FMN-containing domain
por: Burris-Hiday, Sarah D., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1cogo294dlkvoo77f9mum1gap9